Not actual patient.
Not actual patient.
Cisplatin is a powerful medicine used to treat many cancers in children. Over time, cisplatin builds up in the cochlea (cok-lee-ah).
Cochlear damage can begin early and continue even after cisplatin treatment ends. You may not even notice it at first. In the early stages, you may think your child simply isn’t paying attention to things around them. In reality, they may not hear higher-pitched sounds like music or birds. Later, they may not hear lower-pitched sounds like thunder. That’s why it’s important to get your child’s hearing tested before, during, and after treatment.
Symptoms and responses to any treatment may vary so it’s important to talk with your healthcare provider about what is right for your child and to follow your doctor’s recommendations.
Adapted from Langer T, et al.
Most children who have non-metastatic cancer (cancer that has not spread) recover.
However, their hearing loss will last forever, and impact every part of their life
Speech and language skills
Social-emotional development
Academic performance
Career potential
Ability to live independently
Academic performance
Fennec HEARS™ is your single source for both financial and patient support. Call 1-833-7PEDMARK.
Find helpful tools for you or your child.
Please see full Prescribing Information, including Patient Information, for PEDMARK.
PEDMARK is a prescription medicine used to decrease the risk of hearing loss in children 1 month of age and older who are receiving cisplatin for solid tumors (cancer) that have not spread to other parts of the body.
It is not known if PEDMARK is safe and effective when given after cisplatin infusions longer than 6 hours.
It is not known if PEDMARK is safe and effective in children less than 1 month of age. PEDMARK is not recommended in children younger than 1 month of age.